Orally active benzamide antipsychotic agents with affinity for dopamine D2, serotonin 5-HT1A, and adrenergic alpha1 receptors.
Reitz AB, Baxter EW, Codd EE, Davis CB, Jordan AD, Maryanoff BE, Maryanoff CA, McDonnell ME, Powell ET, Renzi MJ, Schott MR, Scott MK, Shank RP, Vaught JL.
Reitz AB, et al. Among authors: maryanoff be, maryanoff ca.
J Med Chem. 1998 Jun 4;41(12):1997-2009. doi: 10.1021/jm970164z.
J Med Chem. 1998.
PMID: 9622541